By A Mystery Man Writer
Full article: Current Molecular and Clinical Landscape of ATRT – The Link to Future Therapies
ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer
Evelien SMITS, Full Professor, PhD
Filip LARDON Full professor & Head research lab Center for
PARP inhibitor resistance in ovarian cancer: Underlying mechanisms and therapeutic approaches targeting the ATR/CHK1 pathway - ScienceDirect
Jinthe VAN LOENHOUT, PhD Student
Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatment - ScienceDirect
Current and future strategies for the treatment of ES-SCLC
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic